News
The report, Get It On Time, highlights systematic failures in Scotland’s hospitals that mean that people with Parkinson’s don’t receive their vital medication at their prescribed times.
The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
New data shows that some people waiting to get Personal Independence Payments has increased to over a year
A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.